They have a BMI of 27 or higher along with a weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes
Emerging evidence suggests that treatment with the dual GLP-1 and GIP receptor agonist, tirzepatide, might prove even more potent than a GLP-1RA alone, to ameliorate NAFLD
10.3390/MOLECULES26082153 115 LeriM.ScutoM.OntarioM
Furthermore, a recent extensive cohort study involving over 33,000 GLP-1 RA users diagnosed with diabetes over a 9-year period indicated no significant increase in pancreatic cancer risk associated with GLP-1 RA use, as evidenced by an HR of 0.50 compared to basal insulin [60]
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication
Applications may be obtained from the District Office by calling 785-476-2218, printed from the districts website at usd110.net (select Classified Application under the district offices link), or by emailing Heidi Struckhoff at [email protected]